Home
Neurocrine Biosciences NBIX paid Tarplin, Downs & Young $80K for lobbying in Q4 2024 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q4 2024
- Client
- Neurocrine Biosciences
- Reported
- 25/01/16
Up 0.0% from last quarter
What else happened in Neurocrine Biosciences around then
Filed or reported within 30 days of the trade day · 24/12/01~25/01/30Neurocrine Biosciences's other lobbying reports
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$60K
$60K
Reported 07/20
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$110K
$110K
Reported 07/20
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$940K
$940K
Reported 07/20
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$60K
$60K
Reported 07/08
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$940K
$940K
Reported 04/20
for Q1